FOR HEALTHCARE PROFESSIONALS
Now FDA Approved!


  • The first and only FDA-approved filler to correct age-related volume
    loss in the midface.1 With optimal treatment, natural-looking results
    last up to 2 years1,2
VOLUMA(TM) box

*Required for
 product purchase.

Download materials here.

  • 1. JUVÉDERM VOLUMA™ XC Directions for Use, 2013.
  • 2. Data on file, Allergan, Inc.
1. JUVÉDERM VOLUMA™ XC Directions for Use, 2013.
 
Kathy
Kathy
Unretouched photos of paid model taken 1 month after treatment.
Tami
Tami
Unretouched photos of paid model taken 1 month after treatment.

Before

Before

After

After
Individual results may vary.
Right
Left
Above

A total of 3.5 mL of JUVÉDERM VOLUMA™ XC was injected into the zygomatic arch, anteromedial cheek, and submalar region.
In the clinical trial, the total volume injected ranged from 1.2 mL to 13.9 mL, with a median of 6.6 mL, to achieve optimal
correction for all 3 subregions.1
A total of 4.8 mL of JUVÉDERM VOLUMA™ XC was injected into the zygomatic arch, anteromedial cheek, and submalar region.
In the clinical trial, the total volume injected ranged from 1.2 mL to 13.9 mL, with a median of 6.6 mL, to achieve optimal
correction for all 3 subregions.1

Logos

Download the JUVÉDERM VOLUMA™ XC logos for use in both printed and online materials.

Download Video

Video

Download the JUVÉDERM VOLUMA™ XC In-Office Patient Video.

Patient Brochure

Download the JUVÉDERM VOLUMA™ XC Patient Brochure.

Please note: Documents are provided in Adobe® Reader® format (PDF). To view PDF documents, you must have the Adobe® Reader® software installed on your computer.

If you do not have Adobe® Reader®, you can download it from the Adobe® website.

Already Registered Email Address

Our records indicate that the email address you entered is already registered on this site.

Thank You for Registering

We will contact you when training is available.